9
ACCEPTED MANUSCRIPT
15
For a review on furan Diels-Alder reactions, see: Kappe CO,
Murphree SS, Padwa A. Tetrahedron. 1997; 53:14179.
For select examples of nitrone formation/[3+2] cycloaddition
1
For general reviews on the Securinega alkaloids, see: (a)
16
Wehlauch R, Gademann K. Asian J. Org. Chem. 2017; doi:
10.1002/ajoc.201700142; (b) Chirkin, E.; Atkatlian, W.; Porée,
F.-H. In The Alkaloids; Knölker, H.-J., Ed.; Academic Press:
New York, 2015; Vol. 74, pp 1-120; (c) Zhang W, Li J-Y, Lan P,
Sun P-H, Wang Y, Ye W-C, Chen W-M. J. Chin. Pharm. Sci.
2011; 20:203; (d) Snieckus, V. In The Alkaloids; Manske, R. H.
F., Ed.; Academic Press: New York, 1973; Vol. 14, pp 425-503.
2 For reviews on the synthesis of Securinega alkaloids, see Ref. 1
and Weinreb, SM. Nat. Prod. Rep. 2009; 26:758.
cascade reactions in total synthesis, see: (a) Davison EC, Fox
ME, Holmes AB, Roughley SD, Smith CJ, Williams GM, Davies
JE, Raithby PR, Adams JP, Forbes IT, Press NJ, Thompson MJ.
J. Chem. Soc., Perkin Trans. 1. 2002; 1494; (b) Stockman RA,
Sinclair A, Arini LG, Szeto P, Hughes DL. J. Org. Chem. 2004;
69:1598; (c) Karatholuvhu MS, Sinclair A, Newton AF, Alcaraz
M-L, Stockman RA, Fuchs PL. J. Am. Chem. Soc. 2006;
128:12656; (d) Wilson MS, Padwa A. J. Org. Chem. 2008;
73:9601; (e) Burrell AJM, Coldham I, Oram N. Org. Lett. 2009;
11:1515; (f) Flick AC, Caballero MJA, Padwa A. Tetrahedron.
2010; 66:3643.
3
(a) Horii Z, Hanaoka M, Yamawaki Y, Tamua T, Saito S,
Shigematsu N, Kotera K, Yoshikawa H, Sato Y, Nakai H,
Sugimoto N, Tetrahdron. 1967; 23:1165; (b) Honda T, Namiki
H, Kudoh M, Watanabe N, Nagase H, Mizutani H. Tetrahedron
Lett. 2000; 41:5927; (c) Liras S, Davoren JE, Bordner J. Org.
Lett. 2001; 3:703; (d) Alibés R, Ballbé M, Busqué F, de March P,
Elias L, Figueredo M, Font J. Org. Lett. 2004; 6:1813; (e) Honda
T, Namiki H, Kaneda K, Mizutani H. Org. Lett. 2004; 6:87; (f)
Dhudshia B, Cooper BFT, Macdonald CLB, Thadani AN. Chem.
Commun. 2009; 463; (g) González-Gálvez D, García-García E,
Alibés R, Bayón P, de March P, Figueredo M, Font J. J. Org.
Chem. 2009; 74:6199; (h) Chen J-H, Levine SR, Buergler JF,
McMahon TC, Medeiros MR, Wood JL. Org. Lett. 2012;
14:4531; (i) Zheng X, Liu J, Ye C-X, Wang A, Wang A-E,
Huang P-Q. J. Org. Chem. 2015; 80:1034.
17 Grigg R, Markandu J. Tetrahedron Lett. 1989; 30:5489.
18
(a) Brown HC, Brown CA. J. Am. Chem. Soc. 1963; 85:1005;
(b) Brown CA, Ahuja VK. J. Org. Chem. 1973; 38:2226; (c)
Brown CA, Ahuja VK. J. Chem. Soc., Chem. Commun. 1973;
553.
19
For a review on the synthetic utility of nickel boride, see:
Khurana JM, Gogia A, Org. Prep. Proc. Int. 1997; 29:1.
20
Lindlar reduction conditions were found to be less consistant
and were plagued by significant amounts of an over-oxidation
byproduct (see Supporting Information).
21 Casey ML, Kemp DS, Paul KG, Cox DD. J. Org. Chem. 1973;
38:2294.
22 Schindler CS, Carreira EM. Chem. Soc. Rev. 2009; 38:3222.
23 Corey EJ, Loh TP. Tetrahedron Lett. 1993; 34:3979.
4
Zhao B-X, Wang Y, Zhang D-M, Huang X-J, Bai L-L, Yan Y,
Chen J-M, Lu T-B, Wang Y-T, Zhang Q-W, Ye W-C. Org. Lett.
24
Several other oxazaborolidine catalysts led to similar results:
2012; 14:3096.
(a) Corey EJ, Shibata T, Lee TW. J. Am. Chem. Soc. 2002;
124:3808; (b) Ryu DH, Corey EJ. J. Am. Chem. Soc. 2003;
125:6388; (c) Liu D, Canales E, Corey EJ. J. Am. Chem. Soc.
2007; 129:1498.
5
For a review on the occurrence and biosynthetic origins of
enantiomeric natural products, see: Finefield JM, Sherman DH,
Kreitman M, Williams RM. Angew. Chem. Int. Ed. 2012;
51:4802.
25
For select reviews on C-H functionalization, see: (a) Godulal
6
For the occurrence of the isoxazolidine moiety in natural
K, Sames D. Science. 2006; 312:67; (b) Davies HML, Manning
JR. Nature. 2008; 451:417; (c) Gutekunst WR, Baran PS. Chem.
Soc. Rev. 2011; 40:1976; (d) McMurray L, O’Hara F, Gaunt MJ.
Chem. Soc. Rev. 2011; 40:1885; (e) Yamaguchi J, Yamaguchi
AD, Itami K. Angew. Chem. Int. Ed. 2012; 51:8960; (f) Chen
DY-K, Youn SW. Chem. Eur. J. 2012; 18:9452; (g) Egger J,
Carreira EM. Nat. Prod. Rep. 2014; 31:449; (h) Qiu Y, Gao S.
Nat. Prod. Rep. 2016; 33:562; (i) Davies HML, Morton D. J.
Org. Chem. 2016; 81:343.
products, see: (a) Berthet M, Cheviet T, Dujardin G, Parrot I,
Martinez J. Chem. Rev. 2016; 116:15235, and references therein;
(b) Nge C-E, Sim K-S, Lim S-H, Thomas NF, Low Y-Y, Kam T-
S. J. Nat. Prod. 2016; 79:2709.
7 Zhao B-X, Wang Y, Zhang D-M, Jiang R-W, Wang G-C, Shi J-
M, Huang X-J, Chen W-M, Che C-T, Ye W-C. Org. Lett. 2011;
13:3888.
8 Parry RJ. Bioorg. Chem. 1978; 7:277.
9
(a) Miyatake-Ondozabal H, Bannwart LM, Gademann K.
26
For recent total syntheses involving late-stage C(sp3)-H
Chem. Commun. 2013; 125:648; (b) Wei H, Qiao C, Liu G, Yang
Z, Li C-C. Angew. Chem. Int. Ed. 2013; 52:620.
functionalizations, see: (a) Hinman A, Du Bois J. J. Am. Chem.
Soc. 2003; 125:11510; (b) Bisai A, West SP, Sarpong R. J. Am.
Chem. Soc. 2008; 130:7222; (c) Chen K, Baran PS. Nature.
2009; 459:824; (d) Stang EM, White MC. Nat. Chem. 2009;
1:547; (e) Yun SY, Zheng J-C, Lee D. J. Am. Chem. Soc. 2009;
131:8413; (f) Huters AD, Quasdorf KW, Styduhar ED, Garg NK.
J. Am. Chem. Soc. 2011; 133:15797; (g) Kawamura S, Chu H,
Felding J, Baran PS. Nature. 2016; 532:90; (h) McCallum ME,
Rasik CM, Wood JL, Brown MK. J. Am. Chem. Soc. 2016;
138:16616; (i) Hung K, Condakes ML, Morikawa T, Maimone
TJ. J. Am. Chem. Soc. 2016; 138:16616; (j) Liu C, Chen R, Shen
Y, Liang Z, Hua Y, Zhang Y. Angew. Chem. Int. Ed. 2017;
56:8187.
10
Intramolecular cycloaddition of 12 would proceed with the
nitrone adding across the alkene with the opposite regiochemistry
as compared to 9 or 10.
11
For recent total syntheses employing biomimetic [3+2] nitrone
cycloadditions, see Ref 10 and: (a) Ma N, Yao Y, Zhao B-X,
Wang Y, Ye W-C, Jiang S. Chem. Commun. 2014; 50:9284; (b)
Hong AY, Vanderwal CD. J. Am. Chem. Soc. 2015; 137:7306;
(c) Hong AY, Vanderwal CD. Tetrahedron. 2016; 73:4160.
12
For synthetic studies towards pyridomacrolidin employing a
biomimetic [3+2] nitrone cycloaddition, see: (a) Irlapati NR,
Baldwin JE, Adlington RM, Pritchard GJ. Org. Lett. 2003;
5:2351; (b) Irlapati NR, Baldwin JE, Adlington RM, Pritchard
GJ, Cowley AR. Tetrahedron. 2006; 62:4603.
27
(a) Schindler CS, Stephenson CRJ, Carreira EM. Angew.
Chem. Int. Ed. 2008; 47:8852; (b) Diethelm S, Schindler CS,
Carreira EM. Org. Lett. 2010; 12:3950; (c) Zipfel HF, Carreira
EM. Org. Lett. 2014; 16:2854.
13
For computational studies of biosynthetic [3+2] nitrone
cycloadditions, see: (a) Krenske EH, Patel A, Houk KN. J. Am.
Chem. Soc. 2013; 135:17638; (b) Painter PP, Pemberton RP,
Wong BM, Ho KC, Tantillo DJ. J. Org. Chem. 2014; 79:432.
28
See the Supporting Information for a summary of the
nucleophiles screened.
14
For an initial communication on this synthesis of virosaine A,
see: Hughes JME, Gleason JL. Angew. Chem. Int. Ed. 2017;
56:10830..